NCT01807065View on ClinicalTrials.gov

Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

June 7, 2013

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2019

Conditions
Adenocarcinoma of the ProstateBone MetastasesHormone-resistant Prostate CancerRecurrent Prostate CancerSoft Tissue MetastasesStage IV Prostate Cancer
Interventions
BIOLOGICAL

sipuleucel-T

Given IV

RADIATION

external beam radiation therapy

Undergo external beam radiation therapy

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (3)

84112

Huntsman Cancer Institute, Univ. of Utah, Salt Lake City

91010

City of Hope Medical Center, Duarte

91030

South Pasadena Cancer Center, Pasadena

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER

NCT01807065 - Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer | Biotech Hunter | Biotech Hunter